Edward Rybicki
Overview
Explore the profile of Edward Rybicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dames N, Rocke E, Pitcher G, Rybicki E, Pfaff M, Moloney C
FEMS Microbiol Lett
. 2024 Nov;
371.
PMID: 39508239
Nano-picoplankton are the dominant primary producers during the postupwelling period in St Helena Bay, South Africa. Their dynamics on short timescales are not well-understood and neither are the community composition,...
2.
Whittle L, Chapman R, Douglass N, Jaffer M, Margolin E, Rybicki E, et al.
Front Immunol
. 2023 Apr;
14:1143034.
PMID: 37063887
East Coast fever is an acute bovine disease caused by the apicomplexan parasite and is regarded as one of the most important tick-vectored diseases in Africa. The current vaccination procedure...
3.
Margolin E, Verbeek M, de Moor W, Chapman R, Meyers A, Schafer G, et al.
Front Plant Sci
. 2022 Jan;
12:798822.
PMID: 35058959
Given the complex maturation requirements of viral glycoproteins and the challenge they often pose for expression in plants, the identification of host constraints precluding their efficient production is a priority...
4.
Margolin E, Allen J, Verbeek M, van Diepen M, Ximba P, Chapman R, et al.
Front Plant Sci
. 2021 Aug;
12:709344.
PMID: 34367227
There is an urgent need to establish large scale biopharmaceutical manufacturing capacity in Africa where the infrastructure for biologics production is severely limited. Molecular farming, whereby pharmaceuticals are produced in...
5.
Pietersen I, van Zyl A, Rybicki E, Hitzeroth I
Pathogens
. 2020 Dec;
9(12).
PMID: 33260725
Vaccine efficacy requires the production of neutralising antibodies which offer protection against the native virus. The current gold standard for determining the presence of neutralising antibodies is the pseudovirion-based neutralisation...
6.
Chapman R, van Diepen M, Galant S, Kruse E, Margolin E, Ximba P, et al.
Vaccines (Basel)
. 2020 Feb;
8(1).
PMID: 32013223
The HIV-1 envelope glycoprotein (Env) is present on the surface of the virion at a very low density compared to most other enveloped viruses. Substitution of various parts of the...
7.
8.
Ma J, Christou P, Chikwamba R, Haydon H, Paul M, Ferrer M, et al.
Plant Biotechnol J
. 2013 Oct;
11(9):1029-33.
PMID: 24119183
Molecular Pharming, the production of recombinant pharmaceuticals through plant biotechnology, has the potential to transform the biologics sector of the pharmaceutical industry. More fascinating however, is how it might be...
9.
Kozicki M, Sasiadek E, Kolodziejczyk M, Komasa J, Adamus A, Maniukiewicz W, et al.
Carbohydr Polym
. 2012 Oct;
91(1):115-27.
PMID: 23044112
In this study, we present facile antimicrobial finishing of cotton textiles. Screen printing was used for surface-finishing of cotton using a printing paste containing silver nitrate. UVC irradiation was applied...
10.
Warzecha H, Mason H, Lane C, Tryggvesson A, Rybicki E, Williamson A, et al.
J Virol
. 2003 Jul;
77(16):8702-11.
PMID: 12885889
Human papillomavirus-like particles (HPV VLPs) have shown considerable promise as a parenteral vaccine for the prevention of cervical cancer and its precursor lesions. Parenteral vaccines are expensive to produce and...